NCT03931993View on ClinicalTrials.gov

A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

April 27, 2017

Study Completion Date

April 27, 2017

Conditions
Seasonal Allergic Rhinitis
Interventions
BIOLOGICAL

Placebo comparator

BIOLOGICAL

Grass MATA MPL

Trial Locations (4)

Unknown

Vedas Research, Edison

Allergy Partners of New Jersey, Teaneck

07712

Atlantic Reseach Center, Ocean City

07081-2515

STARx Asthma and Allergy Center, Springfield

Sponsors
All Listed Sponsors
collaborator

SynteractHCR

INDUSTRY

collaborator

Metronomia Clinical Research GMBH

UNKNOWN

lead

Allergy Therapeutics

INDUSTRY